Val Pavliuchenko, head of Hosanna Studio, suggests replacing inhumane AI prompting with intuitive, high-performance interfaces that bridge the gap between technical power and human desirability While ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

If you've sniffed a cool kid recently, there's a big chance they smelled like the best D.S. & Durga scents. Which scent, exactly? Well, that cool kid probably wouldn't tell you. Luckily, we sniffed ...

What are the qualifications of the people conducting IDTechEx research? Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their ...

A man who hasn’t been able to move or speak for years imagines picking up a cup and filling it with water. In response to the man’s thoughts, a robotic arm mounted on his wheelchair glides forward, ...

In a policy document released this month, China has signaled its ambition to become a world leader in brain-computer interfaces, the same technology that Elon Musk’s Neuralink and other US startups ...

This Collection explores various aspects of micro-nanoarchitectures, nanomaterials (nanowires, nanodots, 2D materials), underlying mechanisms, and applications in energy generation, storage, and ...

People who have lost the ability to move or speak may soon have a new option: surgically implanted devices that link the brain to a computer. More than two decades after researchers first demonstrated ...

In her new film, “Bonjour Tristesse,” and in her writing, the director Durga Chew-Bose knows how to create an atmosphere. By Lindsay Gellman It was a Thursday night in early May, and Durga Chew-Bose ...

BCIs mark a paradigm shift in neurotherapeutics, where cognition and intent can directly influence external digital and mechanical systems. As the technology matures, BCIs are becoming central to ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...